-
European stocks gain as oil prices ease
-
Arteta coy over Lewis-Skelly's Arsenal future after 'emotional' celebration
-
Infantino future should be decided by election says African football chief
-
Romania shuts down nuclear plant as Danube drops
-
Man City star Doku signs five-year contract extension
-
German steel giant Thyssenkrupp weighs options as Rhine drops
-
Fabien Barthez joins Zidane's new France coaching setup
-
US ambassador denounces settler siege as Israel dispatches troops
-
Taiwan chokes mobile internet speeds in drill for Chinese attack
-
Hasan takes 6-55 as Bangladesh claim opening day of Australia Test
-
From Chinese AI to Global ETFs: STARTRADER Launches 45 New 24/7 Stock and ETF CFDs
-
Taiwan says AI agents used in cyberattacks targeting island
-
Tech stocks enjoy rebound after US inflation on mixed day for markets
-
Japan protests Putin's first visit to disputed islands
-
Hasan takes 6-55 as Bangladesh bundle out Australia for 198
-
Kiss wants fit-again Wallabies playmaker Gordon to 'open up' Japan
-
Swiatek sinks Svitolina to set up Rybakina title clash in Toronto
-
British eccentrics push humble garden shed to new heights
-
Australia's Pallister shines, mixed relay record falls as Pan Pacs open
-
Zambia votes with president's economic record on the line
-
Hasan puts Bangladesh in charge as Australia struggle to 183-8
-
Germany's dry rivers spark battle on engineering vs restoration
-
Putin visits Kuril islands claimed by Japan
-
Senators demand inquiry into conditions aboard USS Abraham Lincoln
-
Swiatek downs Svitolina to reach first WTA final of 2026
-
All Blacks' Proctor out of South Africa series, Mo'unga called up
-
Jones says Japan 'watching videos of geese' for Australia clash
-
Bangladesh quick Hasan reduces Australia to 74-4 at lunch
-
Bloodied but unbowed, defending champ Shelton reaches Montreal final
-
Seoul tech leads Asian stock gains as traders cheer US inflation
-
Wallabies make eight changes for return Japan Test
-
Farage and Count Binface go head-to-head in snap UK poll
-
Messi returns after father's death but Miami knocked out of Leagues Cup
-
Afghan students divided over smartphone ban at universities
-
Outflanked by AI, stars fade for South Korea's blind fortune-tellers
-
Japan go back to school for second Australia Test
-
Venezuela govt, opposition wrap up round of post-Maduro talks
-
Matthew McConaughey on his sweet return to the big screen
-
Five things to know about Zambia as it goes to the polls
-
President's economic record on the line as Zambia votes
-
Nakashima holds off Jodar to book first ATP Masters final in Montreal
-
Healthcare Machine Learning Hits Production Scale as Governance Falls Behind, Black Book's Fourth Annual Report Finds
-
iFabric Corp. Announces Record Revenues for Q2 and H1 2026
-
Who Does MTF Body Feminization Surgery?
-
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
-
Magellan Copper and Gold Corp. Forms New Subsidiary Magellan Energy Corp.
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 13
-
3 Home Repairs You Can't Afford to Put Off
-
Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
-
Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
'Getting scary': US aid cuts undermine global fight against TB
The Trump administration's sweeping foreign aid cuts will send tuberculosis cases and deaths soaring around the world, humanitarian workers have warned.
One told AFP that people are already dying from a lack of treatment in the war-torn Democratic Republic of Congo (DRC).
The United States has long been the biggest funder for the global fight against tuberculosis -- once known as consumption -- which is again the world's biggest infectious disease killer after being briefly surpassed by Covid-19.
But President Donald Trump froze US foreign aid after returning to the White House in January, abruptly halting the work of many US-funded programmes against tuberculosis and other health scourges such as HIV and malaria.
Trump's billionaire advisor Elon Musk has boasted of putting the vast US humanitarian agency USAID "through the woodchipper".
On Monday, US Secretary of State Marco Rubio announced that 83 percent of all USAID contracts were officially cancelled. It was unclear which programmes would be spared.
The World Health Organization warned last week that the cuts would endanger millions of lives, pointing out that tuberculosis (TB) efforts averted 3.65 million deaths last year alone.
The change has already brought about a major impact in many developing countries, according to aid workers and activists on the ground.
In the Democratic Republic of Congo, many frontline community workers have been forced to stop helping tuberculosis patients, said Maxime Lunga, who heads a local group called Club des Amis.
Even before the US funding cuts, there was shortage of TB drugs in the country, which is also facing outbreaks of mpox, as well as a mystery illness and a surge in fighting in its conflict-plagued east.
"The chaotic situation is starting to get scary here," said Lunga, who is himself a tuberculosis survivor.
"Right now we are receiving a lot of phone calls from patients asking us how to help them access care," he told AFP.
"We know that some of the patients on waiting lists are now dying because they are not being treated."
- 'People will suffer' -
In Ukraine, another war-battered nation with high TB rates, a programme to teach children about the dangers of tuberculosis was just three days from starting in schools when the US order to stop work came in.
Olya Klymenko, whose group TB People Ukraine spent two years setting up the programme, lamented that the money had been wasted.
It was, she said, a "very bad deal".
Klymenko feared the US cuts would reverse the gains that have been made since she survived TB a decade ago.
"As a person who started receiving treatment when the old approaches were used, I know perfectly well what we have lost now," she told AFP.
"People will suffer a lot."
Lunga and Klymenko's organisations both received US funds through the Stop TB Partnership.
The Geneva-based NGO received a letter from the US government terminating all funding late last month.
It had to share the bad news with 150 community organisations that test, treat and care for patients in affected countries.
Then Stop TB received a new letter last week rescinding the termination.
"The new letter clearly indicates that all work should resume as planned," the organisation's executive director, Lucica Ditiu, told AFP.
But it was still unclear whether the decision was permanent -- or when any new US money would actually be released, she added.
- 'Snowball effect' -
Allowing airborne TB to go untested and untreated could have a "snowball effect" across the world, Ditiu warned.
There are already mutated forms of TB that are resistant to most drugs, and Ditiu feared the US cuts could result in a bug that no treatment can stop.
"Interrupting a treatment for a drug-resistant TB person is horrible, because it will create a bug that will be spread through the air, so me and you and our families or friends can get it," she warned.
The funding cuts were particularly "devastating" because 2024 was the "best year ever" for the fight against TB, Ditiu added.
According to an internal USAID memo by a now-dismissed assistant administrator, the aid cuts will cause rates of tuberculosis and drug-resistant TB to both surge by roughly 30 percent.
"The US will see more cases of hard-to-treat TB arriving at its doorstep," according to the memo, published in the New York Times earlier this month.
The US is already reportedly experiencing the largest TB outbreak in its modern history in Kansas City.
A humanitarian source in Geneva who wished to remain anonymous told AFP the situation was "very dangerous, even for the European Union" because of the risk linked to drug-resistant TB in Ukraine and Georgia.
Ch.P.Lewis--AT